Literature DB >> 14030746

The effect of rheumatoid factors and of antigobulins of immune hemolysis in vivo.

M E KAPLAN, J H JANDL.   

Abstract

Studies were undertaken in man and in the rat comparing the effects of rheumatoid factors and immune antiglobulins on red cells sensitized with incomplete antibodies. The interaction of immune antiglobulins with sensitized red cells produced (a) agglutination in vitro and (b) an accelerated sequestration of the sensitized cells in vivo. In contrast, rheumatoid macroglobulins, although capable of agglutinating Rh-sensitized red cells in vitro, did not modify their destruction in vivo. The failure of rheumatoid factors to function as antiglobulins in vivo appears to reflect their non-reactivity with sensitized cells in whole serum. It is suggested: (a) that the native (7S) gamma globulins of plasma competitively inhibit rheumatoid factors from reacting with fixed antibody in the blood stream; (b) that if these macroglobulins do indeed have pathogenetic activity, this may be limited to body fluids of low protein content.

Entities:  

Keywords:  GAMMA GLOBULIN; HEMOLYSIS; PRECIPITINS; RHEUMATOID FACTOR

Mesh:

Substances:

Year:  1963        PMID: 14030746      PMCID: PMC2180434          DOI: 10.1084/jem.117.1.105

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Reaction of I-131 trace labeled human anti-Rho(D) with red cells.

Authors:  S P MASOUREDIS
Journal:  J Clin Invest       Date:  1959-02       Impact factor: 14.808

2.  The destruction of red cells by antibodies in man. I. Observations of the sequestration and lysis of red cells altered by immune mechanisms.

Authors:  J H JANDL; A R JONES; W B CASTLE
Journal:  J Clin Invest       Date:  1957-10       Impact factor: 14.808

3.  Studies on the serum haptoglobin level in hemoglobinemia and its influence on renal excretion of hemoglobin.

Authors:  C B LAURELL; M NYMAN
Journal:  Blood       Date:  1957-06       Impact factor: 22.113

4.  Quantitative considerations of the rheumatoid factor.

Authors:  J H VAUGHAN; P J ELLIS; H MARSHALL
Journal:  J Immunol       Date:  1958-09       Impact factor: 5.422

5.  Significance of the rheumatoid factor.

Authors:  H G KUNKEL
Journal:  Arthritis Rheum       Date:  1958-08

6.  Hereditary serological human serum groups.

Authors:  R GRUBB; A B LAURELL
Journal:  Acta Pathol Microbiol Scand       Date:  1956

7.  Use of anti-Rh sera for demonstrating agglutination activating factor in rheumatoid arthritis.

Authors:  M V WALLER; J H VAUGHAN
Journal:  Proc Soc Exp Biol Med       Date:  1956-05

8.  Observations on a prozone phenomenon encountered in using the anti-globulin sensitisation test.

Authors:  J J van LOGHEM; M KRESNER
Journal:  Lancet       Date:  1950-12-09       Impact factor: 79.321

9.  The production of potent antihuman globulin (Coombs reagent) in rabbits immunized with serum adjuvant mixtures.

Authors:  C P EMERSON; W FRANKLIN; F C LOWELL
Journal:  J Immunol       Date:  1951-03       Impact factor: 5.422

10.  Characterization of the reactant (gamma globulin factor) in the F II precipitin reaction and the F II tanned sheep cell agglutination test.

Authors:  C L CHRISTIAN
Journal:  J Exp Med       Date:  1958-07-01       Impact factor: 14.307

View more
  6 in total

1.  The potentiating effect of rheumatoid arthritis serum in the immediate phase of nephrotoxic nephritis.

Authors:  J N McCormick; J Day; C J Morris; A G Hill
Journal:  Clin Exp Immunol       Date:  1969-01       Impact factor: 4.330

Review 2.  Splenic pooling and the pathophysiology of hypersplenism.

Authors:  J H Jandl; R H Aster; C E Forkner; A M Fisher; R W Vilter
Journal:  Trans Am Clin Climatol Assoc       Date:  1967

3.  Pooling of platelets in the spleen: role in the pathogenesis of "hypersplenic" thrombocytopenia.

Authors:  R H Aster
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

4.  Polymyositis with plasma cell infiltrate in essential mixed cryoglobulinaemia.

Authors:  C Voll; L C Ang; J Sibley; R Card; K Lefevre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

5.  Portal hypertension and hypersplenism in extrahepatic portal venous obstruction: Are they related?

Authors:  Ragini Kilambi; Anand Narayan Singh; Kumble Seetharama Madhusudhan; Sujoy Pal; Renu Saxena; Nihar Ranjan Dash; Peush Sahni
Journal:  Indian J Gastroenterol       Date:  2018-06-23

6.  [Role of splenectomy in the treatment of non-cirrhotic portal hypertension: about 3 cases].

Authors:  Mohamed Said Belhamidi; Salah Eddine Hammi; Mohamed Bouzroud; Mustapha Benmoussa; Abdelmounaim Ait Ali; Ahmed Bounaim
Journal:  Pan Afr Med J       Date:  2017-09-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.